Revelation Biosciences Inc.
13F holders, Q3 2024 (September 30)7holders
2new positions
2sold out
$0.85avg. 13F price*
At the end of Q3 2024, 7 institutions reported holding Revelation Biosciences Inc. in their 13F filings, unchanged from Q2 2024. 2 opened new positions and 2 sold out. The largest holders were Sabby Management, LLC ($36K), UBS Group AG ($35K) and Susquehanna International Group, LLP ($11K).
- Company
- Revelation Biosciences Inc.
- CUSIP
- 76135L507
- Latest filing quarter
- Q1 2025
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $47K |
| Exits | 2 | $34K |
All 13F filers, Q2 2024 → Q3 2024: 69,118 shares bought and 20,526 shares sold, net +48,592 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 7 holders
| Sabby Management, LLC | 0.50% | New | 42,226 | $36K |
| UBS Group AG | 0.00% | Add +49.8% | 40,945 | $35K |
| Susquehanna International Group, LLP | 0.00% | New | 13,258 | $11K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -49.3% | 2,539 | $2K |
| Bank of America Corp. | 0.00% | Add +123.1% | 29 | $25 |
| Morgan Stanley | 0.00% | Add +20.0% | 6 | $5 |
| POM Investment Strategies, LLC | 0.00% | No change | 1 | $1 |
"% of holder's portfolio" is REVELATION BIOSCIENCES INC's weight in each manager's 13F, not the share of Revelation Biosciences Inc. the manager owns.